MODIFIZIERTE TGF-BETA-OLIGONUKLEOTIDE
European patent · EP2978845 · In force
Register entry
- Publication number
- EP2978845
- Application number
- EP14713467
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Corrected
- Filed
- Mar 27, 2014
- Published
- Feb 3, 2016
- Granted
- Apr 29, 2020
- Protection ends at the latest
- Mar 26, 2034
- Next annual fee due
- Mar 31, 2027
- IPC classes
- C12N 15/113 (2010.01)C07H 21/02 (2006.01)A61K 31/713 (2006.01)A61P 35/00 (2006.01)
- Priority
- EP 13161474 27.03.2013EP 13173078 20.06.2013EP 13199826 30.12.2013
- PCT application
- PCT/EP2014/056221 27.03.2014
- PCT publication
- WO2014/154835 02.10.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- May 20, 2020
Change
Published in Swissreg on 20.05.2020
- Apr 29, 2020
Granted
Published in Swissreg on 29.04.2020
Parties
Inventor
JANICOT, Michel
1180 Brussels, BE
UHLMANN, Eugen
61479 Glashütten, DE
JASCHINSKI, Frank
82178 Puchheim, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.